Printer Friendly

Articles from Chain Drug Review (February 19, 2007)

1-107 out of 107 article(s)
Title Author Type Words
'Fair access' also an issue in Canada. Organization overview 1260
'Firing on all cylinders,' CVS notches another strong year. Financial report 1105
'New openness' adds impetus to category. Vogel, Mike 786
A 'powerful tool to combat rising prescription drug costs'. 936
A dynamic marketplace. Brief article 113
A growing number of patients are opting for generics alternative. 705
A look at contact lens care solutions. Rubino, Peter 415
A proven way of saving money for Medicaid. Coopman, Robert 511
All signs point to continued growth in scar management. Walden, Geoff 1594
American Bioceuticals. Buyers guide 644
Arcadia to acquire PrairieStone. 423
AstraZeneca inks two R&D pacts. 328
At-home heart health tests gaining traction. Brief article 238
B vitamins in demand in wide variety of forms. 524
Blackstone to buy Cardinal's PTS unit. Brief article 192
Branded suppliers' results reflect impact of generics. 771
Bush seeks big cuts in Medicare, Medicaid. 728
CAC scores help predict who is at risk. 443
Cardinal adopts Dossia system. Brief article 268
Cardinal results beat analysts' expectations. 826
Cardiovascular disease hits African-Americans hard. 445
Caremark battle goes down to wire. 811
CCPA study pinpoints cost of Rx dispensing. 625
CE courses online. Website list 396
Chain drug stocks on the rise. Statistical data 1459
Chains strive to find answer to shrink problem. 483
Condoms expected to offer more than protection. 563
Counterfeit drugs are big threat. Brief article 225
Credit facility amended by Longs. Brief article 250
CVS changes way directors are elected. Brief article 159
CVS to ramp up the rollout of MinuteClinics. Brief article 276
Dangers of hypertension subject of new campaign. 530
Defining success: the new shape of the diet pill market. 608
Doctors want faster drug approvals. Brief article 184
Drug chains are outlet of choice. 747
E-Scripts on rise. 585
Enzymes could be next big thing. 351
Everything is ready and set to go at NACDS. Pinto, David 587
FDA first-time generics approvals--2006. Statistical table 1601
FDA moves to enhance drug safety. 697
FDA outlines vision of PDUFA IV. 675
FDA tentative generics approvals--2006. List 2703
Gelita Health Products. 511
Generic drugs continue ascendancy. 355
Global Rx sales advance 5%. 351
GPhA ready to tackle complex issues. Interview 1512
Greenstone is honored by HDMA. Brief article 137
GSK gets O.K to sell weight loss drug as O-T-C. Brief article 312
Heart disease takes heavy toll. 555
Helping retailers seize a major opportunity. Factor, Saul 1129
Impact of Medicare Part D eyed. 601
Indigene Pharmaceuticals. Company overview 487
Industry has stake in trade policy. 426
Insurer uses co-pay policy as incentive. Brief article 174
Inyx to acquire rights to six eye care lines. Brief article 222
ISS. 606
Lilly revamps manufacturing unit. 347
Makers adapt to new reporting rules. Brief article 271
Manufacturers keep introductions coming. 1047
Mason Vitamins. Company overview 547
McKesson capitalizing on per-se acquisition. 387
MedImmune ruling is viewed as a 'victory'. 352
MediZine builds synergies with Rx. Brief article 319
Mihelich tapped to be vice president of corporate development at Breckenridge. Brief article 117
MTM service network is on growth track. 301
Natrol. Company overview 480
New concepts improve heat/cold treatments. Brief article 285
New era begins at Mylan as it begins to assimilate Matrix. 445
New ideas on fighting microbes. Brief article 243
NFI Consumer Products. 593
Nutrition 21. 294
P&G to stress importance of oral health. Brief article 245
Pankow helps new products reach market. 397
Parker to head supervalu marketing. Brief article 115
People aim to cope with chronic pain. 431
Poll: U.S. can do well by doing good. Brief article 263
Polley goes to APhA as it strengthens exec team. 752
Prescription assistance plan touted. Brief article 107
Promising psoriasis treatments in the works. 509
Ranbaxy weighs bid for Merck's generics unit. Brief article 289
RX education gets backing from NACDS. Brief article 220
Rx major component of Giant Eagle format. Brief article 285
RxSchool live online CE. Calendar 143
Sanofi, Bristol-Myers said to weigh merger. Brief article 246
SDM pairs two health care formats. 314
Sector is characterized by dynamism. Coopman, Robert 577
Senate passes minimum wage bill. Brief article 171
Senate to weigh generics policy. 988
Shifts bolster Eisai management ranks. Brief article 214
Solis Brands. Company overview 456
Some retailers start tinkering with generics pricing paradigm. 1102
Specialization hits multivitamins. 711
Spin-off will give Kraft 'enhanced flexibility to grow'. Brief article 326
Studies should serve as wake-up call for Rx. Woldt, Jeffrey 888
Study: Aegerion drug has promise. 381
Sundown. Company overview 298
Suppliers target women's needs. 870
Top generics based on retail dollar sales. Statistical table 1152
Trends bode well for category. Monks, Richard 456
Wal-Mart gives Beahm key Rx post. Brief article 147
Walgreens shows it has merchandising knack. Brief article 287
Weight-control science advances. 447
Wellnx Life Sciences. Company overview 454
Windmill Health Products. 473
Woodcock and Dyer given key posts at FDA. Brief article 272
Wyeth joins forces with Nautilus. 319
Wyeth names president. Brief article 138

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters